Literature DB >> 22585968

Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal models.

Haim Levy1, Shay Weiss, Zeev Altboum, Josef Schlomovitz, Itai Glinert, Assa Sittner, Avigdor Shafferman, David Kobiler.   

Abstract

The virulence of Bacillus anthracis, the causative agent of anthrax, stems from its antiphagocytic capsule, encoded by pXO2, and the tripartite toxins encoded by pXO1. The accepted paradigm states that anthrax is both an invasive and toxinogenic disease and that the toxins play major roles in pathogenicity. We tested this assumption by a systematic study of mutants with combined deletions of the pag, lef, and cya genes, encoding protective antigen (PA), lethal factor (LF), and edema factor (EF), respectively. The resulting seven mutants (single, double, and triple) were evaluated following subcutaneous (s.c.) and intranasal (i.n.) inoculation in rabbits and guinea pigs. In the rabbit model, virulence is completely dependent on the presence of PA. Any mutant bearing a pag deletion behaved like a pXO1-cured mutant, exhibiting complete loss of virulence with attenuation indices of over 2,500,000 or 1,250 in the s.c. or i.n. route of infection, respectively. In marked contrast, in guinea pigs, deletion of pag or even of all three toxin components resulted in relatively moderate attenuation, whereas the pXO1-cured bacteria showed complete attenuation. The results indicate that a pXO1-encoded factor(s), other than the toxins, has a major contribution to the virulence mechanism of B. anthracis in the guinea pig model. These unexpected toxin-dependent and toxin-independent manifestations of pathogenicity in different animal models emphasize the importance and need for a comprehensive evaluation of B. anthracis virulence in general and in particular for the design of relevant next-generation anthrax vaccines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585968      PMCID: PMC3434592          DOI: 10.1128/IAI.00244-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen.

Authors:  Orit Gat; Haim Grosfeld; Naomi Ariel; Itzhak Inbar; Galia Zaide; Yehoshua Broder; Anat Zvi; Theodor Chitlaru; Zeev Altboum; Dana Stein; Sara Cohen; Avigdor Shafferman
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Membrane translocation by anthrax toxin.

Authors:  R John Collier
Journal:  Mol Aspects Med       Date:  2009-06-27

Review 3.  The adenylyl cyclase activity of anthrax edema factor.

Authors:  Wei-Jen Tang; Qing Guo
Journal:  Mol Aspects Med       Date:  2009-06-26

Review 4.  Anthrax toxins: a weapon to systematically dismantle the host immune defenses.

Authors:  Jean-Nicolas Tournier; Silvia Rossi Paccani; Anne Quesnel-Hellmann; Cosima T Baldari
Journal:  Mol Aspects Med       Date:  2009-06-26

Review 5.  Animal models of human anthrax: the Quest for the Holy Grail.

Authors:  Pierre L Goossens
Journal:  Mol Aspects Med       Date:  2009-08-07

Review 6.  The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.

Authors:  Fiorella Tonello; Cesare Montecucco
Journal:  Mol Aspects Med       Date:  2009-08-07

7.  Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome.

Authors:  Theodor Chitlaru; Orit Gat; Haim Grosfeld; Itzhak Inbar; Yael Gozlan; Avigdor Shafferman
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

8.  Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model.

Authors:  Hitendra S Chand; Melissa Drysdale; Julie Lovchik; Theresa M Koehler; Mary F Lipscomb; C Rick Lyons
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

Review 9.  Cellular and systemic effects of anthrax lethal toxin and edema toxin.

Authors:  Mahtab Moayeri; Stephen H Leppla
Journal:  Mol Aspects Med       Date:  2009-07-26

Review 10.  Proteomic studies of Bacillus anthracis.

Authors:  Theodor Chitlaru; Avigdor Shafferman
Journal:  Future Microbiol       Date:  2009-10       Impact factor: 3.165

View more
  21 in total

1.  Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.

Authors:  Itai Glinert; Elad Bar-David; Assa Sittner; Shay Weiss; Josef Schlomovitz; Amir Ben-Shmuel; Adva Mechaly; Zeev Altboum; David Kobiler; Haim Levy
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.

Authors:  Shay Weiss; Zeev Altboum; Itai Glinert; Josef Schlomovitz; Assa Sittner; Elad Bar-David; David Kobiler; Haim Levy
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

3.  Using Telemetry Data to Refine Endpoints for New Zealand White Rabbits Challenged with Bacillus anthracis.

Authors:  David G Dawson; Kristin A Bower; Candace N Burnette; Rebecca K Holt; James R Swearengen; Paul A Dabisch; Angelo Scorpio
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-11-01       Impact factor: 1.232

4.  Treating Anthrax-Induced Meningitis in Rabbits.

Authors:  Amir Ben-Shmuel; Itai Glinert; Assa Sittner; Elad Bar-David; Josef Schlomovitz; Tal Brosh; David Kobiler; Shay Weiss; Haim Levy
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

5.  Germination and amplification of anthrax spores by soil-dwelling amoebas.

Authors:  Rafik Dey; Paul S Hoffman; Ian J Glomski
Journal:  Appl Environ Microbiol       Date:  2012-09-14       Impact factor: 4.792

6.  Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challenge.

Authors:  Julie A Hutt; Julie A Lovchik; Melissa Drysdale; Robert L Sherwood; Trevor Brasel; Mary F Lipscomb; C Rick Lyons
Journal:  Am J Pathol       Date:  2014-10-05       Impact factor: 4.307

7.  In trans complementation of lethal factor reveal roles in colonization and dissemination in a murine mouse model.

Authors:  David E Lowe; Jason Ya; Ian J Glomski
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

8.  Evaluation of the European Committee on Antimicrobial Susceptibility Testing Guidelines for Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis-, Yersinia pestis- and Francisella tularensis-Positive Blood Cultures.

Authors:  Ohad Shifman; Tamar Aminov; Moshe Aftalion; David Gur; Hila Cohen; Elad Bar-David; Ofer Cohen; Emanuelle Mamroud; Haim Levy; Ronit Aloni-Grinstein; Ida Steinberger-Levy; Shahar Rotem
Journal:  Microorganisms       Date:  2021-05-13

9.  Application of CRISPR/Cas9 System for Plasmid Elimination and Bacterial Killing of Bacillus cereus Group Strains.

Authors:  Xiaojing Wang; Yufei Lyu; Siya Wang; Qingfang Zheng; Erling Feng; Li Zhu; Chao Pan; Shenghou Wang; Dongshu Wang; Xiankai Liu; Hengliang Wang
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640

10.  Bacillus anthracis co-opts nitric oxide and host serum albumin for pathogenicity in hypoxic conditions.

Authors:  Stephen St John; Ryan Blower; Taissia G Popova; Aarthi Narayanan; Myung-Chul Chung; Charles L Bailey; Serguei G Popov
Journal:  Front Cell Infect Microbiol       Date:  2013-05-17       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.